LASTACAFT is a Ophthalmic Solution/ Drops in the Human Otc Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Alcaftadine.
| Product ID | 0023-4291_3110f1f0-8f7d-425b-8ed5-99673f085be6 | 
| NDC | 0023-4291 | 
| Product Type | Human Otc Drug | 
| Proprietary Name | LASTACAFT | 
| Generic Name | Alcaftadine | 
| Dosage Form | Solution/ Drops | 
| Route of Administration | OPHTHALMIC | 
| Marketing Start Date | 2021-12-01 | 
| Marketing Category | NDA / | 
| Application Number | NDA022134 | 
| Labeler Name | Allergan, Inc. | 
| Substance Name | ALCAFTADINE | 
| Active Ingredient Strength | 3 mg/mL | 
| Pharm Classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2021-12-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | Y | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0023-4290 | LASTACAFT | alcaftadine | 
| 0023-4291 | LASTACAFT | alcaftadine | 
| 42254-288 | LASTACAFT | alcaftadine | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  LASTACAFT  85168259  4071760 Live/Registered | Allergan, Inc. 2010-11-03 | 
|  LASTACAFT  85088422  4003795 Live/Registered | Allergan, Inc. 2010-07-20 |